Prof. Dr. Thomas Szucs, MD, MBA, MPH, LLM, JSD

is Professor of Pharmaceutical Medicine and Director of The Institute of Pharmaceutical Medicine/European Center of Pharmaceutical Medicine at the University of Basel. He is also a Professor and part-time lecturer for Medical Economics at the University of Zurich and a honorary professor at the University of Peking Health Science Center. 

Previously he was Chief Medical Officer of Hirslanden Holding, the largest private hospital chain in Switzerland. From 1998 to 2001 he was head of the Department of Medical Economics, a joint venture of the University Hospital in Zurich and the Institute of Social and Preventive Medicine of the University of Zurich. Professor Szucs’ former appointments include head of research and founder of the Center of Pharmacoeconomics of the University of Milan, head of the working group for Clinical Economics at the University of Munich, senior consultant at Arthur D. Little Inc and head of the Department of Health Economics at F. Hoffmann-La Roche Ltd. in Basel.

He holds a medical degree from the University of Basel, a Master in Business Administration from the University of St Gallen, Switzerland, a Master of Public Health degree from Harvard University, a LL.M in International Business Law from the University of Zurich and a Doctorate in Law from the Private University of Liechtenstein. Thomas is board certified in Pharmaceutical Medicine as well as in Prevention and Public Health.

He is also member of the editorial board of several scientific journals and has published more than 300 articles, book chapters and monographs. He has worked extensively in the field of pharmaceutical economics and epidemiology. From 2004-2014 he was the president of the Swiss Association of Health Economics. In 2016 Professor Szucs was rated among the 20 most influential economists in Switzerland. In 2020 he was recognized as Global Fellow in Medicines Development by the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine. Since 2013 he started to work as a clinician in genomic medicine.